Cormorant Asset Management LP 13D and 13G filings for Longboard Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:10 pm Purchase |
2024-09-30 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Cormorant Asset Management LP | 2,790,462 8.100% |
648,956 (+30.30%) |
Filing |
| 2024-02-14 3:04 pm Purchase |
2023-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Cormorant Asset Management LP | 2,141,506 9.990% |
339,559 (+18.84%) |
Filing |
| 2023-02-14 3:05 pm Purchase |
2022-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Cormorant Asset Management LP | 1,801,947 9.990% |
420,015 (+30.39%) |
Filing |
| 2022-02-14 3:16 pm Purchase |
2021-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Cormorant Asset Management LP | 1,381,932 9.990% |
42,301 (+3.16%) |
Filing |
| 2021-03-26 4:05 pm Purchase |
2021-03-16 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Cormorant Asset Management LP | 1,339,631 9.990% |
1,339,631 (New Position) |
Filing |